BLUE bluebird bio Inc.: Earnings per share for the trailing year

Public company logo of bluebird bio Inc. (BLUE)

The annual EPS TTM YoY trend captures profit dynamics, where the current parameter equals 87.60. bluebird bio, Inc. (BLUE) monetizes unique treatments for rare blood pathologies by setting multi-million dollar price points for procedures. The operating model relies on external partners for vector manufacturing and clinical oversight. Environmental policy is limited to energy efficiency and the proper disposal of chemical reagents.

BLUE: bluebirdbio.com Net earnings per share for the last 12 months 02/11/2024 - 02/20/2024

bluebirdbio.com - analytical breakdowns and key metrics (BLUE)

- market price and analyst price targets:
- company stock capitalization data:
Initial company analysis:BLUE, Bluebird Bio
Flagship merchandise of bluebird bio, Inc.

Long-term investing requires strict control over the rate of return on capital. For bluebird bio, Inc. (BLUE), which develops breakthrough gene therapy methods, transforming scientific achievements into financial results is critically important. The year-over-year EPS dynamics over the last 12 months measure the percentage change in net income per share, revealing the actual growth rate of profitability. This indicator allows market expectations to be compared with actual business efficiency. A steady increase in this metric confirms the commercial viability of patient-saving technologies.

Direct competitors

Earnings per share for the trailing year TEM (Tempus AI Inc)|QGEN (Qiagen Group) - Net earnings per share for the last 12 months|Earnings per one share for the last 12 months IONS (Ionis Pharma)|Earnings per share for the last twelve months Repligen|Earnings per share for the last twelve months RNA|Net earnings per share (EPS TTM) CRSP|Earnings per share for the last twelve months WGS (GeneDx)|Ultragenyx Pharmaceutical - Net earnings per share for the last 12 months|Net earnings per share (EPS TTM) Beam Tx BEAM|Sarepta Therapeutics - Net earnings per share (EPS TTM)|Twist Bioscience (TWST) - Net earnings per share for the last 12 months|TXG: Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months Intellia Therapeutics Inc (NTLA)|STOK (stoketherapeutics.com) - Net earnings per share (EPS TTM)|BLFS (BioLife Corp) - Earnings per share for the last four quarters|Earnings per share for the last twelve months Wave Life Sciences Ltd. (WVE)|Earnings per share for the last four quarters MAZE|sionnatx.com - Net earnings per share for the last 12 months|Earnings per share for the trailing year PRME|TSHA - Earnings per share for the last twelve months|Net earnings per one share for the last twelve months uniQure Corp|meiragtx.com (MGTX) - Earnings per share for the last twelve months|Earnings per share for the last 12 months RGNX|Net earnings per share for the last 12 months SLDB|Net earnings per share (EPS TTM) Ocugen Inc|Earnings per share for the last twelve months PacBio Corp (PACB)|Net earnings per share for the last four quarters Benitec Corp|Net earnings per share (EPS TTM) DSGN (Design Therapeutics, Inc.)|Net earnings per share (EPS TTM) rocketpharma.com RCKT|4DMT - Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months Lexeo Therapeutics, Inc.|Korro Bio (KRRO) - Earnings per share for the last twelve months|Earnings per share for the last 12 months EDIT|SLN (Silence Therapeutics plc) - Net earnings per share (EPS TTM)|proqr.com (PRQR) - Net earnings per share for the last four quarters|Net earnings per share for the last 12 months CDXS (Codexis Bio)|SGMO - Net earnings per one share for the last twelve months|Nautilus Biotechnology, Inc. - Net earnings per share for the last 12 months|Net earnings per share for the trailing year Metagenomi, Inc|Precision BioSciences - Net earnings per share (EPS TTM)|Net earnings per share for the trailing year generationbio.com (GBIO)|Boundless Bio Inc (BOLD) - Earnings per share for the last twelve months|Exicure Inc. - Earnings per share for the trailing year|IMNN (imunon.com) - Net earnings per share (EPS TTM)|Phio Pharmaceuticals - Earnings per one share for the last 12 months|Earnings per share for the last twelve months Mustang Bio Corp (MBIO)|Net earnings per share (EPS TTM) TransCode (RNAZ)|Net earnings per share (EPS TTM) BNGO (bionanogenomics.com)|APDN (Applied DNA Sciences Inc) - Earnings per one share for the last 12 months|IPA - Earnings per share for the last twelve months|Earnings per share for the trailing year OMGA (Omega Therapeutics)|OMIC: Net earnings per share (EPS TTM)|RGLS (Regulus Therapeutics Inc.) - Earnings per share for the last twelve months|Earnings per share for the last twelve months Syros Pharmaceuticals Inc.|Telesis Bio Inc. (TBIO) - Net earnings per share for the last four quarters|Earnings per share for the last twelve months traconpharma.com (TCON)|Earnings per share for the last four quarters UBX